Epigenetic Network in Immunometabolic Disease
暂无分享,去创建一个
F. Paneni | S. Costantino | M. Geiger | S. Mohammed | E. Gorica | Valentina Delfine | Alessia Mongelli | Alessandro Mengozi | F. Ruschitzka | A. Mongelli
[1] M. Mokry,et al. Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition , 2023, Rheumatology.
[2] Howard Y. Chang,et al. Engineering circular RNA for enhanced protein production , 2022, Nature Biotechnology.
[3] F. Paneni,et al. Epi-Drugs in Heart Failure , 2022, Frontiers in Cardiovascular Medicine.
[4] W. Tee,et al. Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer , 2022, Frontiers in Cell and Developmental Biology.
[5] Abeer M. Mahmoud. An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions , 2022, International journal of molecular sciences.
[6] F. Ruschitzka,et al. The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1. , 2021, Antioxidants & redox signaling.
[7] R. Taneja,et al. Crosstalk Between Inflammatory Signaling and Methylation in Cancer , 2021, Frontiers in Cell and Developmental Biology.
[8] Yi Luan,et al. Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases , 2021, Frontiers in Cardiovascular Medicine.
[9] Ming-Ming Zhou,et al. The Functions of BET Proteins in Gene Transcription of Biology and Diseases , 2021, Frontiers in Molecular Biosciences.
[10] Pashupati P. Mishra,et al. DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases , 2021, Nature Communications.
[11] Sumit Kumar Verma,et al. Hepatic Regulator of G Protein Signaling 6 (RGS6) drives non-alcoholic fatty liver disease by promoting oxidative stress and ATM-dependent cell death , 2021, Redox biology.
[12] P. Wordsworth,et al. MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis , 2021, Current Rheumatology Reports.
[13] Christina Nedeva. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis , 2021, Biomolecules.
[14] Sandip Paul,et al. Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules , 2021, Redox biology.
[15] Hongbing Wang,et al. Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC , 2021, International journal of molecular sciences.
[16] Jia Guo,et al. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective , 2021, Clinical epigenetics.
[17] S. Mastana,et al. DNA methylation of tumour necrosis factor (TNF) alpha gene is associated with specific blood fatty acid levels in a gender‐specific manner , 2021, Molecular genetics & genomic medicine.
[18] E. Resch,et al. High-Throughput Screening for CEBPD-Modulating Compounds in THP-1-Derived Reporter Macrophages Identifies Anti-Inflammatory HDAC and BET Inhibitors , 2021, International journal of molecular sciences.
[19] D. Kass,et al. Cellular and molecular pathobiology of heart failure with preserved ejection fraction , 2021, Nature Reviews Cardiology.
[20] J. Eubanks,et al. Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders , 2021, Frontiers in Genetics.
[21] M. Zheng,et al. Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer , 2021, Advanced science.
[22] S. Wasiak,et al. BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes , 2020, Clinical Epigenetics.
[23] Weibing Qin,et al. Epigenetic Regulation of Spermatogonial Stem Cell Homeostasis: From DNA Methylation to Histone Modification , 2020, Stem Cell Reviews and Reports.
[24] F. Montecucco,et al. Statins: Epidrugs with effects on endothelial health? , 2020, European journal of clinical investigation.
[25] R. Boon,et al. The Long Non-coding Road to Atherosclerosis , 2020, Current Atherosclerosis Reports.
[26] C. Pears,et al. Methylation-directed acetylation of histone H3 regulates developmental sensitivity to histone deacetylase inhibition , 2020, bioRxiv.
[27] Han-Teo Lee,et al. The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis , 2020, Journal of lipid and atherosclerosis.
[28] Joseph A. Hill,et al. Metabolic Inflammation in Heart Failure with Preserved Ejection Fraction. , 2020, Cardiovascular research.
[29] S. Ahmed,et al. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus , 2020, Clinical Epigenetics.
[30] Yuanyuan Li. Modern Epigenetics Methods in Biological Research. , 2020, Methods.
[31] Xiaofei Xu,et al. MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3 , 2020, Frontiers in Immunology.
[32] S. Chernausek,et al. Role of metformin in epigenetic regulation of placental mitochondrial biogenesis in maternal diabetes , 2020, Scientific Reports.
[33] A. Shilatifard,et al. Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation , 2020, Nature Genetics.
[34] M. Banach,et al. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways , 2020, Clinical Reviews in Allergy & Immunology.
[35] Young-Kook Kim,et al. Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification , 2020, International journal of molecular sciences.
[36] W. Tan,et al. Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease , 2020, British journal of pharmacology.
[37] Ziquan Lv,et al. Metformin and Its Benefits for Various Diseases , 2020, Frontiers in Endocrinology.
[38] K. Kelnar,et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours , 2020, British Journal of Cancer.
[39] K. Kalantar-Zadeh,et al. Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. , 2020, JAMA.
[40] J. Davie,et al. Genomic landscape of transcriptionally active histone arginine methylation marks, H3R2me2s and H4R3me2a, relative to nucleosome depleted regions. , 2020, Gene.
[41] Xiang Wu,et al. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non–small cell lung cancer cells via endoplasmic reticulum stress‐mediated degradation of Mcl‐1 , 2020, Molecular carcinogenesis.
[42] C. Misbah,et al. The effect of shear stress reduction on endothelial cells: A microfluidic study of the actin cytoskeleton. , 2020, Biomicrofluidics.
[43] Pashupati P. Mishra,et al. Epigenetic Link Between Statin Therapy and Type 2 Diabetes , 2020, Diabetes Care.
[44] S. Di Bartolomeo,et al. Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis , 2020, International journal of molecular sciences.
[45] S. Greenway,et al. The Impact of Epigenetics on Cardiovascular Disease. , 2020, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[46] D. Freimark,et al. Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy , 2020, Cardiovascular Diabetology.
[47] R. Holmdahl,et al. Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis. , 2019, Journal of autoimmunity.
[48] Chih-Hong Wang,et al. The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet. , 2019, The Journal of nutritional biochemistry.
[49] S. Ohlmeier,et al. Heat shock protein 90 is downregulated in calcific aortic valve disease , 2019, BMC Cardiovascular Disorders.
[50] Xingyi Chen,et al. Association of Hepatic Global DNA Methylation and Serum One‐Carbon Metabolites with Histological Severity in Patients with NAFLD , 2019, Obesity.
[51] Zhou Zhou,et al. Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets , 2019, Hepatology.
[52] Rashidul Islam,et al. A Brief Overview of lncRNAs in Endothelial Dysfunction-Associated Diseases: From Discovery to Characterization , 2019, Epigenomes.
[53] S. Wasiak,et al. Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism , 2019, Clinical Epigenetics.
[54] A. Jackson,et al. A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin. , 2019, The Journal of investigative dermatology.
[55] P. Newsholme,et al. Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes , 2019, Cancers.
[56] J. Krycer,et al. Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism. , 2019, American journal of physiology. Endocrinology and metabolism.
[57] F. Milagro,et al. DNA methylation markers in obesity, metabolic syndrome, and weight loss , 2019, Epigenetics.
[58] Y. Böttcher,et al. Genetics and epigenetics in obesity. , 2019, Metabolism: clinical and experimental.
[59] O. Lushchak,et al. Prenatal Malnutrition-Induced Epigenetic Dysregulation as a Risk Factor for Type 2 Diabetes , 2019, International journal of genomics.
[60] M. Blüher. Obesity: global epidemiology and pathogenesis , 2019, Nature Reviews Endocrinology.
[61] Liming Chen,et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart , 2019, Cardiovascular Diabetology.
[62] A. Brunet,et al. Linking Lipid Metabolism to Chromatin Regulation in Aging. , 2019, Trends in cell biology.
[63] F. Paneni,et al. Epigenetic processing in cardiometabolic disease. , 2019, Atherosclerosis.
[64] A. Akhmedov,et al. Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity , 2019, European heart journal.
[65] A. Akhmedov,et al. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy , 2019, European heart journal.
[66] C. Greer,et al. Histone H3 lysine K4 methylation and its role in learning and memory , 2019, Epigenetics & Chromatin.
[67] J. Pelisek,et al. Atherosclerosis Is an Epigenetic Disease , 2018, Trends in Endocrinology & Metabolism.
[68] J. Hirschhorn,et al. Disruption of the Igf2 gene alters hepatic lipid homeostasis and gene expression in the newborn mouse. , 2018, American journal of physiology. Endocrinology and metabolism.
[69] Traci L. Marin,et al. AMPK: An Epigenetic Landscape Modulator , 2018, International journal of molecular sciences.
[70] T. Lüscher,et al. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc. , 2018, International journal of cardiology.
[71] R. Ventura,et al. Epigenetic Inheritance: Concepts, Mechanisms and Perspectives , 2018, Front. Mol. Neurosci..
[72] Kai Li,et al. HDAC9 promotes brain ischemic injury by provoking IκBα/NF-κB and MAPKs signaling pathways. , 2018, Biochemical and biophysical research communications.
[73] P. Newsholme,et al. Epigenetic effects of metformin: From molecular mechanisms to clinical implications , 2018, Diabetes, obesity & metabolism.
[74] S. Armstrong,et al. The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia. , 2018, Blood.
[75] D. Landau,et al. Maternal smoking during pregnancy and the risk of pediatric cardiovascular diseases of the offspring: A population-based cohort study with up to 18-years of follow up. , 2018, Reproductive toxicology.
[76] Yuan-ting Xiao,et al. Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells , 2018, BMC Complementary and Alternative Medicine.
[77] Jun Ren,et al. ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1α deacetylation , 2018, International Journal of Obesity.
[78] J. McCubrey,et al. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise , 2018, Oncotarget.
[79] S. Subramaniam,et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function , 2018, Nature Communications.
[80] V. Dolinsky,et al. Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring , 2018, Critical reviews in clinical laboratory sciences.
[81] Maite Huarte,et al. The multidimensional mechanisms of long noncoding RNA function , 2017, Genome Biology.
[82] G. Hotamisligil,et al. Foundations of Immunometabolism and Implications for Metabolic Health and Disease. , 2017, Immunity.
[83] Yiping Huang,et al. Knockdown of lncRNA MIR31HG inhibits adipocyte differentiation of human adipose-derived stem cells via histone modification of FABP4 , 2017, Scientific Reports.
[84] Kihyun Park,et al. Writing, erasing and reading histone lysine methylations , 2017, Experimental &Molecular Medicine.
[85] H. Gu. Genetic, Epigenetic and Biological Effects of Zinc Transporter (SLC30A8) in Type 1 and Type 2 Diabetes. , 2017, Current diabetes reviews.
[86] K. Otsu,et al. Inflammation and metabolic cardiomyopathy. , 2017, Cardiovascular research.
[87] X. Dai,et al. SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia–reperfusion injury , 2017, Basic Research in Cardiology.
[88] Traci L. Marin,et al. AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1 , 2017, Science Signaling.
[89] A. Näär,et al. miRNA regulation of LDL-cholesterol metabolism. , 2016, Biochimica et biophysica acta.
[90] R. Barrès,et al. The Emerging Role of Epigenetics in Inflammation and Immunometabolism , 2016, Trends in Endocrinology & Metabolism.
[91] Rajarshi Pal,et al. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter , 2016, Journal of Molecular Medicine.
[92] E. Tsochatzis,et al. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.
[93] G. Jena,et al. Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: A comparative study with metformin. , 2016, Chemico-biological interactions.
[94] S. Samuel,et al. Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin , 2016, The Journal of Pharmacology and Experimental Therapeutics.
[95] A. Corvalán,et al. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. , 2015, World journal of gastroenterology.
[96] S. Dalton,et al. Metabolic Reprogramming of Stem Cell Epigenetics. , 2015, Cell stem cell.
[97] N. Brockdorff,et al. The interplay of histone modifications – writers that read , 2015, EMBO reports.
[98] Jack A. Taylor,et al. Non-Steroidal Anti-Inflammatory Drug Use and Genomic DNA Methylation in Blood , 2015, PloS one.
[99] Yu Zhang,et al. siRNA Versus miRNA as Therapeutics for Gene Silencing , 2015, Molecular therapy. Nucleic acids.
[100] Yawei Xu,et al. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism. , 2015, International journal of cardiology.
[101] C. Franceschi,et al. Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[102] F. Paneni,et al. Role of oxidative stress in endothelial insulin resistance. , 2015, World journal of diabetes.
[103] N. Ozaki,et al. Long-Term Pancreatic Beta Cell Exposure to High Levels of Glucose but Not Palmitate Induces DNA Methylation within the Insulin Gene Promoter and Represses Transcriptional Activity , 2015, PloS one.
[104] Gaurang C. Patel,et al. Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications. , 2015, Biochemical pharmacology.
[105] K. Kodys,et al. microRNA‐122 regulates hypoxia‐inducible factor‐1 and vimentin in hepatocytes and correlates with fibrosis in diet‐induced steatohepatitis , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[106] Angelo Avogaro,et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. , 2015, JACC. Heart failure.
[107] Mitsuo Kato,et al. Diabetic nephropathy—emerging epigenetic mechanisms , 2014, Nature Reviews Nephrology.
[108] P. Jagodziński,et al. Role of epigenetic mechanisms in the development of chronic complications of diabetes. , 2014, Diabetes research and clinical practice.
[109] C. Ling,et al. Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets , 2014, BMC Medicine.
[110] F. Buttitta,et al. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.
[111] J. Loscalzo,et al. Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease (2013 Grover Conference Series) , 2014, Pulmonary circulation.
[112] F. Nassir,et al. Role of Mitochondria in Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.
[113] Liewei Wang,et al. AMPK regulates histone H2B O-GlcNAcylation , 2014, Nucleic acids research.
[114] S. Chien,et al. Epigenetic Mechanism in Regulation of Endothelial Function by Disturbed Flow: Induction of DNA Hypermethylation by DNMT1 , 2014, Cellular and molecular bioengineering.
[115] M. Skopkova,et al. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed , 2014, Diabetologia.
[116] S. Murphy,et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. , 2013, Gastroenterology.
[117] V. Anisimov. Metformin: Do we finally have an anti-aging drug? , 2013, Cell cycle.
[118] David A. Johnson,et al. Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium. , 2013, Antioxidants & redox signaling.
[119] Elizabeth A. McClellan,et al. The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation. , 2013, Cell metabolism.
[120] N. Yuldasheva,et al. Endothelium-specific insulin resistance leads to accelerated atherosclerosis in areas with disturbed flow patterns: a role for reactive oxygen species. , 2013, Atherosclerosis.
[121] Stephanie A. Tammen,et al. Epigenetics: the link between nature and nurture. , 2013, Molecular aspects of medicine.
[122] R. DeFronzo,et al. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease , 2013, Nutrients.
[123] Y. Dang,et al. Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET , 2013, PloS one.
[124] Irene Cantone,et al. Epigenetic programming and reprogramming during development , 2013, Nature Structural &Molecular Biology.
[125] M. Cantley,et al. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs , 2013, Inflammopharmacology.
[126] L. Tsai,et al. Histone acetylation: molecular mnemonics on the chromatin , 2013, Nature Reviews Neuroscience.
[127] M. Myers,et al. Zinc Transporters, Mechanisms of Action and Therapeutic Utility: Implications for Type 2 Diabetes Mellitus , 2012, Journal of nutrition and metabolism.
[128] C. Scheibenbogen,et al. High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy , 2012, European journal of heart failure.
[129] Abdullah Al Mamun,et al. Maternal Smoking During Pregnancy Predicts Adult Offspring Cardiovascular Risk Factors – Evidence from a Community-Based Large Birth Cohort Study , 2012, PloS one.
[130] Alexander S. Banks,et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. , 2012, Physiological reviews.
[131] C. Benner,et al. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. , 2012, Blood.
[132] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[133] S. I. Park,et al. AMP‐activated protein kinase inhibits TGF‐β‐induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300 , 2012, Journal of cellular physiology.
[134] S. Chien,et al. Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow , 2012, Proceedings of the National Academy of Sciences.
[135] Chaowei Wu,et al. Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages , 2011, PloS one.
[136] Y. Furukawa,et al. Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish , 2011, PloS one.
[137] J. Mehta,et al. Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. , 2011, American journal of physiology. Heart and circulatory physiology.
[138] R. Hajjar,et al. Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. , 2011, Journal of molecular and cellular cardiology.
[139] Lars Bullinger,et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. , 2011, Cancer cell.
[140] S. Subramaniam,et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation , 2011, Proceedings of the National Academy of Sciences.
[141] G. Sánchez-Rivera,et al. Inflammation, Oxidative Stress, and Obesity , 2011, International journal of molecular sciences.
[142] J. Fuscoe,et al. Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet. , 2011, Molecular nutrition & food research.
[143] Andrew J. Bannister,et al. Regulation of chromatin by histone modifications , 2011, Cell Research.
[144] N. Damjanov,et al. HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis , 2011, Molecular medicine.
[145] David Carling,et al. Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation , 2010, Science.
[146] M. Haigis,et al. Sirtuins regulate key aspects of lipid metabolism. , 2010, Biochimica et biophysica acta.
[147] B. Richelsen,et al. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants , 2010, International Journal of Obesity.
[148] Meredith B. Baker,et al. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. , 2010, Biochemical and biophysical research communications.
[149] D. Lebeche,et al. Diabetic cardiomyopathy: signaling defects and therapeutic approaches , 2010, Expert review of cardiovascular therapy.
[150] T. Down,et al. Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure , 2010, PloS one.
[151] H. Kee,et al. Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. , 2009, Journal of molecular and cellular cardiology.
[152] T. Rauch,et al. Insulin Gene Expression Is Regulated by DNA Methylation , 2009, PloS one.
[153] M. Turunen,et al. Epigenetics and atherosclerosis. , 2009, Biochimica et biophysica acta.
[154] T. Hansen,et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.
[155] P. Puigserver,et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.
[156] Francisco J Alcaín,et al. Sirtuin activators , 2009, Expert opinion on therapeutic patents.
[157] P. Barnes,et al. Role of HDAC2 in the pathophysiology of COPD. , 2009, Annual review of physiology.
[158] P. Visscher,et al. DNA methylation profiles in monozygotic and dizygotic twins , 2009, Nature Genetics.
[159] M. Yamakuchi,et al. miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.
[160] O. Olivieri,et al. Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. , 2008, Atherosclerosis.
[161] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[162] S. Kersten,et al. PPARs, Obesity, and Inflammation , 2006, PPAR research.
[163] T. Roseboom,et al. The Dutch famine and its long-term consequences for adult health. , 2006, Early human development.
[164] E. Olson,et al. Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10 , 2006, Cell.
[165] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[166] K. Makar,et al. DNA Methylation Is a Nonredundant Repressor of the Th2 Effector Program1 , 2004, The Journal of Immunology.
[167] David Haynes,et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. , 2003, Journal of periodontal research.
[168] R. Robertson,et al. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. , 2003, Diabetes.
[169] Z. Stein,et al. The Dutch famine birth cohort study: design, validation of exposure, and selected characteristics of subjects after 43 years follow-up. , 1993, Paediatric and perinatal epidemiology.
[170] D. Porte,et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.
[171] C. Logie,et al. HDAC11 is a regulator of diverse immune functions. , 2018, Biochimica et biophysica acta. Gene regulatory mechanisms.
[172] G. Rutter,et al. SLC30A8 mutations in type 2 diabetes , 2014, Diabetologia.
[173] Xiaoling Li. SIRT1 and energy metabolism. , 2013, Acta biochimica et biophysica Sinica.
[174] S. Chien,et al. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.
[175] Yuzhi Zhang,et al. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. , 2010, Biochemical and biophysical research communications.
[176] E. Olson,et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.
[177] P. Davies,et al. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology , 2009, Nature Clinical Practice Cardiovascular Medicine.
[178] G. Semenza. Transcriptional regulation of gene expression: Mechanisms and pathophysiology , 1994, Human mutation.